CN1306968C - Calcium alginate gel microsphere soft tissue reinforced material and its preparation method and application - Google Patents
Calcium alginate gel microsphere soft tissue reinforced material and its preparation method and application Download PDFInfo
- Publication number
- CN1306968C CN1306968C CNB2003101247041A CN200310124704A CN1306968C CN 1306968 C CN1306968 C CN 1306968C CN B2003101247041 A CNB2003101247041 A CN B2003101247041A CN 200310124704 A CN200310124704 A CN 200310124704A CN 1306968 C CN1306968 C CN 1306968C
- Authority
- CN
- China
- Prior art keywords
- calcium
- calcium alginate
- gel bead
- soft tissue
- alginate gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
The present invention relates to a soft tissue reinforcing material of a calcium alginate gelatin microsphere and a preparation method thereof. The soft tissue reinforcing material is prepared by mixing a calcium alginate gelatin microsphere with 0.1 to 4.0%(w/v) of sodium alginate solution, wherein the particle diameter of the calcium alginate gelatin microsphere is from 1 to 2000 mum; the volume ratio of the calcium alginate gelatin microsphere to the sodium alginate solution is from 10:1 to 10:30. The preparation method comprises: firstly, the sodium alginate solution is prepared into the calcium alginate gelatin microsphere which is then mixed with the sodium alginate solution according to the volume ratio of 10:1 to 10:30 so as to prepare the microsphere into a gelatin state. The soft tissue reinforcing material is mainly used for the minimally invasive treatment of diseases caused by structural relaxation of partial soft tissues, such as stress urinary incontinence, gastroesophageal reflux, unilateral vocal cord paralysis, etc. The soft tissue reinforcing material can be used in the field of facial beautification, such as breast plump, face-plasty, etc. The soft tissue reinforcing material can be implanted by a subcutaneous injection method and an intradermal injection method. Meanwhile, the soft tissue reinforcing material can be implanted by other implanting method according to requirements.
Description
Technical field
The present invention relates to a kind of local injection and implant the soft tissue enhancement material, relate in particular to a kind of calcium alginate gel bead soft tissue enhancement material.
The invention still further relates to the preparation method of above-mentioned material.
The invention still further relates to the application of above-mentioned material.
Background technology
At present at stress incontinence, gastroesophageal reflux disease and unilateral vocal cord paralysis etc. because the disease treatment that the local soft tissue structural relaxation caused adopts operation suspention and the local means such as reinforcing material of implanting to treat [document 1:Ghoniem GM more, Elgamasy AN, Elsergany R, et al.Grades of intrinsic spincteric deficiency (ISD) associated with female stressurinary incontinence.Int Urogynecol J, 2002:13 (2): 99-105.].Wherein, local injection is implanted the soft tissue enhancement material and is belonged to Wicresoft and hinder Therapeutic Method.The principle of this Therapeutic Method is: with some drugs and the lax soft tissue part of chemicals injecting structure, improve the partial relaxation degree, improve the ability of local proof pressure, thereby make its normal function of this organized renewing or outward appearance.Aesthetic medicine fields such as this Therapeutic Method also is widely used in and enlarges the bosom, facial plasty.This Therapeutic Method, because clinical operation is simple to operate, the patient suffering is few, and therapeutic effect is remarkable, so clinical practice is more.The key problem in technology of this Therapeutic Method is the development of embedded material, require embedded material to meet no antigen (non-antigenic), no animal migration (non-migrating), do not have again requirement [document 2:Bent AE such as absorbability (non-resorbable) and easy transplantability (easily implantable), Tutrone RT, McLennan MT, et al.Treatment of intrinsic sphincter deficiency usingautologous ear chondrocytes as a bulking agent.Neurourol Urodyn, 2001; 20 (2): 157-165.].Embedded material [the document 3:Van Kerrebroeck P that is used for this respect experimentation and clinical treatment at present, Ter Meulen F, Farrelly E, et al.Treatment of stress urinaryincontinence:recent developments in the role of urethral injection.Urol Res, 2003; 30 (6): 356-362.] have 1) the politef microsphere, it is easy to migration in vivo bibliographical information, and can produce granuloma in the part; 2) autologous fat is though good biocompatibility absorbs rapid, poor effect again in the body; 3) glutaraldehyde cross-linking bovine collagen albumen easily produces anaphylaxis, and trace glutaraldehyde is residual harmful; 4) silicones ball, ceramic microsphere etc., owing to reasons such as implantation mode and costs, application also is restricted.
Summary of the invention
The object of the present invention is to provide a kind of that be easy to inject, to calcium alginate gel bead soft tissue enhancement material human body safety, lower-cost.
Another object of the present invention is to provide a kind of method for preparing above-mentioned material.
For achieving the above object, soft tissue enhancement material provided by the invention is that the sodium alginate soln of 0.1-4.0% mixes and to form by calcium alginate gel bead and w/v, form mixture and implant the soft tissue enhancement material as local injection, wherein the particle diameter of calcium alginate gel bead is 1-2000 μ m, and the ratio of calcium alginate gel bead and sodium alginate soln counts 10 by volume: 1-10: 30.
Preparation method of the present invention and parameter are as follows:
The raw material that the present invention adopts is to be widely used in polysaccharide biomaterial sodium alginate biomedical research and application, that have excellent biological compatibility.
The present invention is 0.1～4.0% sodium alginate soln with w/v, at 0.01～1.0mol/LCaCl
2Solution is coagulation bath or is under the condition of decentralized photo with calcium carbonate, calcium lactate, calcium oxalate granule, preparation calcium alginate gel bead (CAM), and the particle diameter of calcium alginate gel bead is between 1～2000 μ m.
Again with the sodium alginate soln uniform mixing of calcium alginate gel bead and 0.1～4.0% (w/v), the mixed proportion of calcium alginate gel bead and sodium alginate is 10: 1～10: 30 (volume ratio), thereby prepares calcium alginate gel bead soft tissue enhancement material.More than operation is all carried out under aseptic condition.
Need to prove, about the method for preparing calcium alginate gel bead is a known technology, all can prepare calcium alginate gel bead of the present invention such as methods such as adopting static sessile drop method, Pneumatic Liquid dripping method, emulsifying/internal gelation, membrane emulsifying/internal gelation.For simplicity's sake, the present invention is not described in detail these known technologies.The play-by-play of relevant these known technologies can be consulted:
Static sessile drop method [consult document: Hommel M, Sun A M, Goosen M F A.Dropletsgeneraion.Canadian patent No.1241598,1988];
Pneumatic Liquid dripping method [consult document: Miyawaki O., Nakamura K., Yano T..Agric.Biol.Chem.1980,44:2865-2870];
The emulsifying/internal gelation [is consulted document: Poncelet D, Lencki R, Beaulieu C et al.Production of alginate beads by emulsification/internal gelation.I.Methodology.Appl.Microbiol.Biotechnol., 1992,38:39～45; ], [Poncelet D, Poncelet De Smet B, Beaulieu C et al.Production of alginate beads byemulsification/internal gelation.II.Physicochemistry.Appl.Microbiol.Biotechnol., 1995,43:644～650; ], [Liu Qun, Ma Xiaojun, Liu tuck inside the sleeve hole, a kind of emulsifying/internal gelation prepares the method for calcium alginate gel beads, Chinese patent, application number 01109449.4, publication number 1374338];
Membrane emulsifying/internal gelation [consulting document: Liu hole of tucking inside the sleeve, Ma Xiaojun, Liu Qun, a kind of membrane emulsifying/internal gelatinizing coupled process for preparing calcium alginate gel beads, Chinese patent, application number 01104365.2, publication number 1373000].
Calcium alginate gel bead of the present invention and sodium alginate soln can be to mix or two kinds of distinct methods such as dispersion:
1. the calcium alginate gel bead for preparing sucks in the sodium alginate soln by utensils such as suction pipes, makes its mix homogeneously by stirring, and forms gel state;
2. sodium alginate soln is dispersed in the calcium alginate gel bead under stirring, and forms gel state.
Calcium alginate gel bead local injection provided by the invention implants that the soft tissue enhancement material is primarily aimed at stress incontinence, gastroesophageal reflux disease, unilateral vocal cord paralysis etc. because treatment is hindered by the Wicresoft of the disease that the local soft tissue structural relaxation is caused, also can be widely used in simultaneously enlarge the bosom, aesthetic medicine field such as facial plasty.
The present invention has following effect:
1. after the calcium alginate gel bead soft tissue enhancement material of preparation is implanted, can be stably fixed in the local organization or on every side;
2. after calcium alginate gel bead soft tissue enhancement material is implanted, can form the protuberance entity in the part, and keep definite shape, have higher-strength, the volume conservation rate is more than 82%;
3. after calcium alginate gel bead soft tissue enhancement material is implanted, only form thin fibers encapsulation layer on every side in local organization (protuberance entity), do not produce significantly inflammatory reaction, histological examination is normal;
4. after calcium alginate gel bead soft tissue enhancement material was implanted, laboratory animal regional nodes histological examination proof calcium alginate gel bead did not have migration;
5. after calcium alginate gel bead soft tissue enhancement material was implanted, body can keep normal activities, does not produce toxic and side effects;
6. after calcium alginate gel bead soft tissue enhancement material is implanted, dissect and reclaim calcium alginate gel bead, calcium alginate gel bead still can keep higher sphericity, not have a distortion substantially, and keeps certain intensity.
Compare with the present invention, the feature and the effect of background technology are as follows:
1. simple calcium alginate gel injection;
2. will adopt different gel process, add the homology fibroblast and use the injection injection effect of the sodium alginate preparation of modifying to contrast by RGD sequence peptide;
3. concrete gel process has preceding calcium alginate gelization of injection and injection back calcium alginate gelization;
4. zoopery shows, each average external volume conservation rate of organizing eight week back subcutaneous injections protuberance entities does not wait 19% to 88%, does not add wherein that the highest average external volume conservation rate is 58% in the experimental group of homology fibroblast;
5. histological examination shows at protuberance and has formed the thin layer fibers encapsulation around the entity.
Description of drawings
Fig. 1: vernier caliper measurement mouse subcutaneous injection animal model protuberance entity parameter.
The specific embodiment
All be that to prepare calcium alginate gel bead with the static sessile drop method be that example describes among the following embodiment.
Embodiment 1
The material preparation of calcium alginate gel bead soft tissue enhancement: under the aseptic condition, 2.0% (w/v) sodium alginate soln is at 1.0mol/L CaCl
2Solution is to prepare particle diameter mainly at the calcium alginate gel bead of 400～600 μ m by the static sessile drop method under the condition of coagulation bath, mix with 10: 30 volume ratios with the sodium alginate soln of 0.5% (w/v) then, obtain the calcium alginate gel bead embedded material.
Embodiment 2
The material preparation of calcium alginate gel bead soft tissue enhancement: under the aseptic condition, 0.5% (w/v) sodium alginate soln is at 0.01mol/L CaCl
2Solution is to prepare particle diameter mainly at the calcium alginate gel bead of 250-800 μ m by the static sessile drop method under the condition of coagulation bath, mix with 10: 10 volume ratios with the sodium alginate soln of 2.0% (w/v) then, obtain the calcium alginate gel bead embedded material.
Embodiment 3
The material preparation of calcium alginate gel bead soft tissue enhancement: under the aseptic condition, 1.5% (w/v) sodium alginate soln is at 0.1mol/L CaCl
2Solution is to prepare particle diameter mainly at the calcium alginate gel bead of 100-600 μ m by the static sessile drop method under the condition of coagulation bath, mix with 10: 15 volume ratios with the sodium alginate soln of 1.0% (w/v) then, obtain the calcium alginate gel bead embedded material.
Embodiment 4
The material preparation of calcium alginate gel bead soft tissue enhancement: under the aseptic condition, 2.0% (w/v) sodium alginate soln is at 1.0mol/L CaCl
2Solution is to prepare particle diameter mainly at the calcium alginate gel bead of 500-1000 μ m by the static sessile drop method under the condition of coagulation bath, mix with 10: 2 volume ratios with the sodium alginate soln of 3.5% (w/v) then, obtain the calcium alginate gel bead embedded material.
Application examples
Calcium alginate gel bead soft tissue enhancement material mouse subcutaneous injection is implanted zoopery.
Receptor: kunming mice, the male and female dual-purpose, 30,18～22g, available from Dalian Medical Univ zoopery center, normal diet is fed, random diet, room temperature (22～25) ℃.
Mice is divided into two groups, 15 every group.Use microsyringe at mouse back subcutaneous injection 0.8ml calcium alginate gel bead soft tissue enhancement material for first group, produce protuberance entity (semiellipsoid, see accompanying drawing 1), in injection back same day, 1,2,3 ..., measure protuberance entity parameters (protuberance physical length a, protuberance entity width b, protuberance entity height c) 8 weeks, calculate protuberance entity volume (2 π abc/3) and protuberance entity volume conservation rate (be defined as this time protuberance entity measuring volume and swell the percentage ratio of ratio of entity measuring volume the first time).2,4,8 weeks were put to death the part mice in the injection back, reclaimed calcium alginate gel bead, and made tissue slice, carried out histological examinations such as H E dyeing.Organize in contrast for second group, at mouse back subcutaneous injection 0.8ml 0.9% (w/v) NaCl solution (normal saline), form the protuberance entity, observe and measure protuberance entity change in volume with microsyringe.
Zoopery is the result show, swells entity volume conservation rate generally within 90%, and the calcium alginate gel bead of 8 weeks back recovery is still complete, and keeps sphericity preferably.Physiological activity state and the body weight of animal are normal.Histological examination shows, injects local organization and only forms thin fibers encapsulation layer, significantly inflammatory reaction of generation on every side.The histological examination of laboratory animal regional nodes shows that calcium alginate gel bead does not have migration; Control group mice protuberance entity all disappeared in 1 day.
Zoopery proof calcium alginate gel bead local injection embedded material has higher intensity, can be good at fixing at the implanting tissue position, and biocompatibility is good, meets the basic demand of implanting the soft tissue enhancement material as local injection.
Comparative example: according to document 1 report, the injection of use calcium alginate gel, and adopt different gel process and adding homology fibroblast and use the sodium alginate of modifying by RGD sequence peptide to compare, 8 all zoopery results show, each average external volume conservation rate of organizing eight week back subcutaneous injections protuberance entities does not wait 19% to 88%, does not add wherein that the highest average external volume conservation rate is 58% in the experimental group of homology fibroblast.And, though add the volume conservation rate that has improved the protuberance entity with the fibril archeocyte to a certain extent, also brought problems such as difficult storage, clinical practice popularization difficulty and use cost increase substantially simultaneously.Add RGD and not only can increase substantially cost, and this result of study shows that also it adds not improve injects the average external volume conservation rate that the back forms the protuberance entity.
Claims (6)
1. calcium alginate gel bead soft tissue enhancement material is that the sodium alginate soln of 0.1-4.0% mixes and forms gel state by calcium alginate gel bead and w/v, wherein:
The particle diameter of calcium alginate gel bead is 1-2000 μ m;
The ratio of calcium alginate gel bead and sodium alginate soln counts 10 by volume: 1-10: 30.
2. method for preparing the described calcium alginate gel bead soft tissue enhancement of claim 1 material, its key step is, under aseptic condition:
A) being coagulation bath with the solubility calcium saline solution of 0.01～1.0mol/L or being decentralized photo with the slightly solubility calcium salt, is that 0.1～4.0% sodium alginate soln is prepared into calcium alginate gel bead with w/v;
B) be that 0.1～4.0% sodium alginate soln is to mix in 10: 1～10: 30 by volume with calcium alginate gel bead and w/v, make calcium alginate gel bead soft tissue enhancement material.
3. preparation method as claimed in claim 2 is characterized in that, calcium alginate gel bead is that sodium alginate soln is dispersed in the calcium alginate gel bead under stirring with mixing of sodium alginate soln among the step b, and forms gel state.
4. preparation method as claimed in claim 2 is characterized in that, calcium alginate gel bead is that calcium alginate gel bead is sucked in the sodium alginate soln with mixing of sodium alginate soln among the step b, stirs to make its mix homogeneously, and forms gel state.
5. preparation method as claimed in claim 2 is characterized in that, described solubility calcium saline solution is a calcium chloride solution; Described slightly solubility calcium salt is calcium carbonate, calcium lactate or calcium oxalate.
6. preparation method as claimed in claim 2 is characterized in that, the preparation calcium alginate gel bead adopts static sessile drop method, Pneumatic Liquid dripping method, emulsifying-internal gelation or membrane emulsifying/internal gelation method among the step a.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101247041A CN1306968C (en) | 2003-12-18 | 2003-12-18 | Calcium alginate gel microsphere soft tissue reinforced material and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101247041A CN1306968C (en) | 2003-12-18 | 2003-12-18 | Calcium alginate gel microsphere soft tissue reinforced material and its preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1628862A CN1628862A (en) | 2005-06-22 |
| CN1306968C true CN1306968C (en) | 2007-03-28 |
Family
ID=34845055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2003101247041A Expired - Fee Related CN1306968C (en) | 2003-12-18 | 2003-12-18 | Calcium alginate gel microsphere soft tissue reinforced material and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1306968C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101831002B (en) * | 2009-03-11 | 2011-11-16 | 中国科学院大连化学物理研究所 | Preparation method of sodium alginate for tissue engineering |
| CN103285375A (en) * | 2013-05-09 | 2013-09-11 | 中国药科大学 | Phycocyanin microsphere preparation and preparation method thereof |
| CN106421900B (en) * | 2016-09-30 | 2019-04-26 | 深圳先进技术研究院 | The 3D printing slurry of tissue recovery support, tissue recovery support and its preparation method and application |
| CN113980341B (en) * | 2021-12-20 | 2022-12-13 | 上海应用技术大学 | Preparation method of calcium alginate gel balls |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09192471A (en) * | 1996-01-24 | 1997-07-29 | Kirin Brewery Co Ltd | Production of alginate gel sphere |
| CN1374338A (en) * | 2001-03-12 | 2002-10-16 | 中国科学院大连化学物理研究所 | Emulsifying and internal gelifying process of preparing calcium alginate gel beads |
-
2003
- 2003-12-18 CN CNB2003101247041A patent/CN1306968C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09192471A (en) * | 1996-01-24 | 1997-07-29 | Kirin Brewery Co Ltd | Production of alginate gel sphere |
| CN1374338A (en) * | 2001-03-12 | 2002-10-16 | 中国科学院大连化学物理研究所 | Emulsifying and internal gelifying process of preparing calcium alginate gel beads |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1628862A (en) | 2005-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11633518B2 (en) | Graft scaffold for cartilage repair and process for making same | |
| Wallace et al. | Collagen gel systems for sustained delivery and tissue engineering | |
| US5633001A (en) | Composition and a method for tissue augmentation | |
| CN101918049A (en) | Monolithic in-situ cross-linked alginate implants | |
| CN105979976A (en) | Methods for adhering tissue surfaces and materials and biomedical uses thereof | |
| CN103834053A (en) | Injectable crosslinked hyaluronic acid gel and preparation method thereof | |
| JP2017164562A (en) | Method of manufacturing bioactive gel from extracellular matrix material | |
| JPH11505734A (en) | Injectable hydrogel composition | |
| CA2304093A1 (en) | Improved hydrogel for tissue engineering | |
| CN107308494A (en) | A kind of injection collagen, preparation method and filler | |
| CN106038478B (en) | A kind of porous microsphere of glucose-sensitive/polymer plural gel and its preparation method and application | |
| CN102348464A (en) | Injectable biomaterials | |
| CN108404204A (en) | Silk fibroin hydrogel | |
| CN110066500A (en) | Degradable injection class polylactic acid filler of one kind and preparation method thereof | |
| CN1318100C (en) | Chitosan-calcium alginate gel microsphere soft tissue reinforced material and its preparation method and application | |
| CN106456533B (en) | The composition of the collagen stroma comprising cyclodextrin incorporation for biomedical applications | |
| CN105188668B (en) | Parenteral delivery systems based on low molecular weight methylcellulose | |
| CN1306968C (en) | Calcium alginate gel microsphere soft tissue reinforced material and its preparation method and application | |
| AU5698698A (en) | Improved hydrogel for tissue engineering | |
| CN1398584A (en) | Slow-releasing bFGF-PLGA microball and its prepn and use | |
| CN103819694A (en) | Silk fibroin hydrogel having cell compatibility, and its preparation method | |
| CN102725005A (en) | Polymer gel formulation | |
| CN115317665B (en) | Polyester particle composite temperature-sensitive instant gel subcutaneous implant | |
| CN107376010A (en) | A kind of injection crosslinking polyglutamic acid gel micro-ball suspension and preparation method thereof | |
| CN104307040A (en) | Injectable hydrogel with controlled release capacity and for tissue engineering, and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070328 Termination date: 20161218 |